Potentially Dilutive Securities (Details) - Schedule of diluted net loss per common share - shares	3 Months Ended
Mar. 31, 2023	Mar. 31, 2022
Schedule of Diluted Net Loss Per Common Share [Abstract]
Potentially dilutive securities	7,208,843	5,254,883
Options to purchase common stock [Member]
Schedule of Diluted Net Loss Per Common Share [Abstract]
Potentially dilutive securities	7,177,605	4,712,659
Warrants to purchase common stock [Member]
Schedule of Diluted Net Loss Per Common Share [Abstract]
Potentially dilutive securities	31,238	31,238
Convertible Debt [Member]
Schedule of Diluted Net Loss Per Common Share [Abstract]
Potentially dilutive securities		510,986

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration